author-photo

Robert Hullsiek

University of Minnesota

6

Papers

53

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Arming of iPSC-Derived NK Cells Expressing a Novel CD64 Fusion Receptor with Therapeutic Antibodies Represents a Novel Off-the-Shelf, Antigen-Targeting Strategy for Cancer

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Simultaneous Engagement of Tumor and Stroma Targeting Antibodies by Engineered NK-92 Cells Expressing CD64 Controls Prostate Cancer Growth.

2021 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (0)
Engineered iPSC-Derived NK Cells Expressing Recombinant CD64 for Enhanced ADCC

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Expression of a Recombinant High Affinity IgG Fc Receptor by Engineered NK Cells as a Docking Platform for Therapeutic mAbs to Target Cancer Cells.

2018 Frontiers in Immunology
Show All
- Source
- Cite
- Save
Citations (20)
Sleeping Beauty Insertional Mutagenesis in Mice Identifies Drivers of Steatosis-Associated Hepatic Tumors

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (27)